Keurig Dr Pepper Stock Jumps 1.9% – Potential for Further Growth?

Keurig Dr Pepper stock is trading -5.81% below its average target price of $36.83 after marking a 1.9% during today's evening session. Analysts are giving the Large-Cap Beverages company an average rating of buy and target prices ranging from $27.0 to $41.0 per share.

Keurig Dr Pepper's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.5%. The stock's short ratio is 2.03. The company's insiders own 21.92% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 73.2%. In conclusion, we believe there is positive market sentiment regarding Keurig Dr Pepper.

Institutions Invested in Keurig Dr Pepper

Date Reported Holder Percentage Shares Value
2024-03-31 Capital World Investors 7% 103,792,739 $3,600,569,973
2024-03-31 Vanguard Group Inc 6% 90,840,391 $3,151,253,039
2024-03-31 Blackrock Inc. 6% 87,484,784 $3,034,847,036
2024-03-31 FMR, LLC 6% 81,010,706 $2,810,261,279
2024-03-31 Wellington Management Group, LLP 3% 47,703,173 $1,654,823,005
2024-03-31 Capital International Investors 3% 44,246,469 $1,534,909,948
2024-03-31 State Street Corporation 3% 44,010,906 $1,526,738,268
2024-03-31 Price (T.Rowe) Associates Inc 2% 23,654,577 $820,577,243
2024-03-31 Geode Capital Management, LLC 2% 21,425,241 $743,241,580
2024-03-31 Invesco Ltd. 1% 18,771,426 $651,180,742
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.